NONSURGICAL CONTOURING WITH DONATED ADIPOSE TISSUE
What Is alloClae Breast Contouring?
alloClae is a sterile, hydrated adipose-tissue allograft made from donated human tissue. It contains non-viable adipocytes, extracellular matrix, lipids, and connective tissue. It is placed in localized subcutaneous areas where fat naturally exists to provide cushioning and structural support.
For selected breast concerns, Dr. Howarth may consider alloClae for modest, localized contour refinement without liposuction to harvest your own fat. It is nonsurgical, even though this page sits in the Breast family so patients can compare it directly with surgical breast choices.
alloClae is not a breast implant, living fat transfer, stem-cell treatment, or large-volume augmentation. The product makes no biological or regenerative claim, and long-term aesthetic data are still developing.
MATCH THE METHOD TO THE CONTOUR
Breast Concerns alloClae May—or May Not—Address
The best use is a small, clearly defined soft-tissue contour concern. Consultation separates a localized deficit from implant position, capsule, skin laxity, breast position, or a need for broader revision.
- Localized implant-edge visibility or rippling in selected areas
- A small contour depression or transition that needs softening
- Modest cleavage, upper-pole, or symmetry refinement
- A patient with limited donor fat who wants to avoid liposuction
- A post-surgical contour issue that does not require implant or capsule correction
alloClae is not intended to create a predictable cup-size change or replace surgery when implant position, capsule, skin, breast position, or substantial volume is the leading issue.
LOCALIZED GOALS. REALISTIC SCALE.
alloClae Breast Contouring Candidacy and Consultation
A possible candidate is a healthy adult with a modest, localized soft-tissue contour concern who understands the donor-tissue source, alternatives, risks, and limits. It may be especially relevant when there is too little donor fat for meaningful grafting or when avoiding a liposuction donor site matters.
Consultation reviews implants or prior breast surgery, breast position, skin and tissue thickness, imaging and screening history, health, medications, allergies, nicotine exposure, healing, and the exact change requested. Dr. Howarth may recommend observation, fat transfer, implant exchange or revision, a breast lift, augmentation, or no procedure instead.
PLACEMENT REQUIRES SURGICAL JUDGMENT
Why a Plastic Surgeon Should Direct Breast alloClae Planning
Breast contour concerns can come from the soft-tissue envelope, implant, capsule, breast position, scar, or more than one layer. A good evaluation does not force every visible edge or asymmetry into an injectable solution.
Ashley Howarth, MD, FACS, evaluates the complete breast anatomy and explains when a small subcutaneous correction may be reasonable, when surgery addresses the cause more directly, and when treatment should not proceed.
PLASTIC SURGERY
OF SURGEONS
SCOTTSDALE · MODERN OFFICE SETTING
FROM FIRST QUESTION TO A CLEAR PLAN
alloClae Breast Consultation and Patient Care Coordination
Your patient care coordinator helps organize consultation, records, estimates, forms, and follow-up logistics. Dr. Howarth and her clinical team make the medical recommendation, review donor-tissue considerations, and explain alternatives.
Start with the exact concern.
Share the area, prior procedures, goals, timing, and the best way to reach you so the team can route the consultation appropriately.
Anatomy determines the options.
Dr. Howarth evaluates the tissue layer, scale, alternatives, donor-tissue considerations, risks, and whether treatment should proceed.
Logistics follow the recommendation.
If alloClae fits, the team provides the proposed area, amount or staging approach, estimate, preparation, aftercare, and follow-up plan.
COMPARE SCALE, SOURCE, AND TRADEOFFS
Breast Contouring Options
alloClae
A donated human adipose-tissue matrix for selected localized subcutaneous contour refinement without a liposuction donor site.
Fat Transfer
Uses your own harvested fat and treats a donor area, with variable graft survival and operative recovery.
Implant Revision
Addresses implant size, position, rupture, capsule, or device-related concerns that an injectable cannot correct.
Lift or Augmentation
Changes breast position, skin envelope, or overall volume when the requested change is larger than localized contouring.
MAP · PLACE · REASSESS
What to Expect With Breast alloClae
The plan is area-specific. Product amount, access, comfort measures, staging, and follow-up are individualized after examination. The official Instructions for Use note that alloClae’s use with local anesthetics has not been evaluated.
The cause is identified.
Dr. Howarth examines the soft-tissue concern and determines whether the implant, capsule, breast position, skin, or another issue changes the recommendation.
The exact area is mapped.
The team reviews donor-tissue consent, risks, alternatives, product amount, access points, comfort plan, aftercare, and the possibility that surgery may fit better.
Small changes are assessed over time.
The material is placed into the selected subcutaneous contour and the area is reassessed as early swelling, firmness, and tissue response evolve.
CLEAR INFORMATION. INFORMED CHOICES.
Breast alloClae Safety, Risks, and Limitations
alloClae is donated human tissue regulated as a human cellular and tissue-based product. Donor screening and processing reduce risk but cannot eliminate every risk. The official Instructions for Use report possible local and systemic reactions and make no biological claim.
Possible Risks and Reactions Include
- Pain, tenderness, swelling, bruising, redness, or discoloration
- Bleeding, hematoma, infection, delayed healing, or fluid collection
- Lumps, cysts, nodules, firmness, contour irregularity, or asymmetry
- Allergic, immune, or anaphylactic reaction, plus the residual disease-transmission risk of donated human tissue
- An unsatisfactory change, need for more treatment, or need for surgical correction
What alloClae Cannot Guarantee
- A specific volume, shape, symmetry, or duration of correction
- The same behavior as living fat transferred from your own body
- A substitute for an implant, lift, skin-removal procedure, or weight loss
- That one session will address every contour difference
- A complication-free treatment or a result unchanged by aging and tissue change
HEALING AND RESULTS EVOLVE
Recovery After Breast alloClae
Recovery is generally centered on the treated breast area rather than a liposuction donor site. The exact course depends on placement, amount, access points, prior surgery, and whether another procedure is performed.
Tenderness, bruising, fullness, firmness, or asymmetry may be more noticeable before the area settles.
Work, exercise, compression, sleeping position, and travel instructions depend on the location, access points, and any combined procedure.
Dr. Howarth evaluates healing, tissue response, symmetry, and whether observation or another step is appropriate.
No exact duration can be promised. Aging, weight change, tissue quality, healing, and the amount placed all influence the visible result.
PATIENT CASE SUMMARIES
alloClae Breast Patient Case Summaries
These deidentified patient case summaries show how Ashley Howarth, MD, FACS, evaluated localized breast contour concerns and distinguished a small subcutaneous volume deficit from an implant, capsule, skin-envelope, or breast-position problem. Identifying information is omitted. Each case reflects an individual clinical decision and does not predict another patient’s treatment or outcome.
Case 01
IMPLANT RIPPLING
Localized implant-edge visibility with thin breast tissue required comparison of alloClae, fat transfer, and implant revision
Patient presentation
The patient reported a small area of implant rippling or edge visibility, especially when leaning forward or wearing fitted clothing.
Clinical evaluation
Dr. Howarth’s evaluation separated a localized soft-tissue coverage deficit from implant malposition, capsular contracture, rupture, and a broader device problem.
Treatment decision
The consultation compared targeted alloClae placement, autologous fat transfer, observation, and implant revision, with implant and capsule stability determining the appropriate path.
Clinical rationale
A small coverage concern and a mechanical implant problem can look similar but require very different treatment strategies.
Case boundary
alloClae cannot repair a ruptured implant, correct implant position, treat a capsule, or guarantee complete camouflage of rippling.
Case 02
POST-EXPLANT CONTOUR
A localized breast hollow after implant removal required assessment of skin, scars, remaining tissue, and the scale of volume loss
Patient presentation
After implant removal and healing, the patient was concerned about a discrete depression rather than restoration of the former implant volume.
Clinical evaluation
Dr. Howarth assessed scar tethering, vascularity, breast position, skin contraction, residual tissue, imaging history, and whether a lift was also needed.
Treatment decision
The consultation compared alloClae and fat transfer for the small stable hollow while treating broader deflation or descent as a surgical—or no-treatment—decision.
Clinical rationale
The plan depended on whether the visible issue was missing soft-tissue volume, contracted scar, loose skin, or breast position.
Case boundary
alloClae is not a substitute for an implant and is not intended to recreate large-volume augmentation after explantation.
Case 03
ASYMMETRY
A small cleavage or upper-pole contour difference was evaluated for side-specific breast contouring
Patient presentation
The patient described a focal difference between the breasts at the medial contour, upper pole, or transition near an implant edge.
Clinical evaluation
Measurements documented native asymmetry, breast position, tissue thickness, implant status when present, and the exact subcutaneous area involved.
Treatment decision
The consultation compared side-specific alloClae placement, fat grafting, observation, and surgical correction for the clearly mapped deficit.
Clinical rationale
The plan focused on the deficient tissue layer without implying that every breast difference can or should be made identical.
Case boundary
Exact symmetry, a specific volume change, and a particular duration of correction cannot be guaranteed.
Case 04
LIMITED DONOR FAT
Limited donor fat brought alloClae into the discussion for a small breast contour deficit—not large-volume augmentation
Patient presentation
The patient wanted to soften one localized contour transition and preferred to avoid, or could not support, a meaningful liposuction donor site.
Clinical evaluation
The consultation compared the requested change with donor-fat availability, breast tissue capacity, skin quality, prior surgery, and the amount of correction needed.
Treatment decision
The small subcutaneous deficit was evaluated for alloClae; an implant, staged fat transfer, observation, or no procedure remained the alternatives for a larger goal.
Clinical rationale
Avoiding a donor site was relevant only because the scale and tissue layer of the concern matched what an adipose-tissue matrix could reasonably address.
Case boundary
alloClae is donated human tissue, not the patient’s living fat, and it is not biologically identical to fat transfer.
Case 05
SURGERY FIT BETTER
Breast descent, loose skin, or implant malposition was not reframed as an injectable contour problem
Patient presentation
The patient asked whether alloClae could improve upper-breast emptiness when the breast also sat lower or an implant had shifted.
Clinical evaluation
Dr. Howarth evaluated nipple and breast position, skin envelope, implant pocket, capsule, tissue thickness, scars, and the patient’s desired scale of change.
Treatment decision
The evaluation redirected the discussion to a breast lift, augmentation, implant exchange or revision, fat transfer, observation, or no procedure instead of alloClae.
Clinical rationale
An injectable matrix adds localized volume; it does not reposition the breast, tighten loose skin, or correct an implant pocket.
Case boundary
The smaller procedure was not the safer or more effective choice because it did not address the anatomic cause.
Case 06
NOT A CUP-SIZE TREATMENT
A request for a predictable cup-size increase fell outside the intended scale of alloClae breast contouring
Patient presentation
The patient sought noticeable overall breast enlargement and asked whether several alloClae treatments could replace augmentation.
Clinical evaluation
The consultation clarified desired size, breast position, skin and tissue capacity, implant preferences, donor fat, risk tolerance, and recovery priorities.
Treatment decision
The discussion shifted to implant-based augmentation, fat transfer, a lift with augmentation, or no procedure rather than localized alloClae placement.
Clinical rationale
The method needed to match the scale of change; a targeted contour material was not presented as predictable whole-breast augmentation.
Case boundary
No specific cup size, shape, symmetry, or duration can be promised with alloClae.
YOUR QUESTIONS, ANSWERED
alloClae Breast Contouring Frequently Asked Questions
alloClae is a sterile, hydrated adipose-tissue allograft made from donated human tissue. It contains non-viable adipocytes, extracellular matrix, lipids, and connective tissue for localized subcutaneous cushioning and support.
No. It is a nonsurgical injectable treatment. This page appears in the Breast family so it can be compared honestly with breast surgery when the underlying concern may require an implant, capsule, lift, or other operative solution.
It is better suited to selected localized contour refinement than a predictable cup-size change. Patients seeking broader volume or position change should compare augmentation, fat transfer, lift, or revision options.
It may be considered for selected localized soft-tissue coverage concerns. Rippling can also reflect tissue thickness, implant position, implant choice, or capsule issues, so examination is essential.
Fat transfer uses your own fat harvested by liposuction and involves a donor site. alloClae uses processed donated human adipose tissue and does not require fat harvesting. They are not biologically identical.
It comes from donated human adipose tissue. Processing and donor screening are described in the official Instructions for Use, but a residual risk of disease transmission cannot be completely eliminated.
The Instructions for Use describe non-viable adipocytes and make no biological claim. It should not be marketed as a stem-cell or regenerative treatment.
An exact duration cannot be promised, and long-term aesthetic data are still developing. The visible course may vary with placement, amount, tissue quality, healing, aging, and weight change.
Possible risks include pain, swelling, bruising, infection, bleeding, cysts, nodules, firmness, asymmetry, allergic or immune reactions, anaphylaxis, discoloration, unsatisfactory contour, and residual disease-transmission risk.
Dr. Howarth may recommend observation, fat transfer, implant revision or exchange, breast lift, augmentation, or no procedure depending on the actual cause and scale of the concern.
BEGIN HERE
Request a Consultation
Tell us what you are considering. A member of our patient care team will follow up with consultation availability and next steps.
Megan S.
Patient Coordinator
Prefer to talk or text?
